BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
about
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNALong non-coding RNAs in anti-cancer drug resistanceBreast Cancer Anti-Estrogen Resistance 4 (BCAR4) Drives Proliferation of IPH-926 lobular Carcinoma Cells.Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNAMicroarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancerAbsent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.STAT signaling in different breast cancer sub-types.Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancerThe long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.Integrated genomic and molecular characterization of cervical cancer.Breast cancer stem cells programs: enter the (non)-code.Somatic Host Cell Alterations in HPV Carcinogenesis.Potentially functional variants in lncRNAs are associated with breast cancer risk in a Chinese population.LncRNA BCAR4 promotes colon cancer progression via activating Wnt/β-catenin signaling.Matrix Factorization Based Data Fusion for the Prediction of lncRNA-disease Associations.Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.Deciphering the roles of lncRNAs in breast development and disease.Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
P2860
Q27011221-77D7EC34-4168-4ECE-A8C6-DB2594BD9F4AQ28072366-6D9402B8-88E5-4AF6-9D97-122F5FFE327EQ35758871-6F81C14B-2D2B-407A-8F5F-A8D4CF260BD7Q35961138-BDE706DE-FD9F-4873-938D-1C886742BC51Q36213198-E89F083B-FB93-4BA3-8DC6-EE7C4404493CQ37022410-B2A74318-70F0-47A2-9E65-02528C6713A8Q37086768-1275A415-90E2-4750-90E7-590267790FB0Q37137065-E7D77E82-3C30-41B8-AADA-A7D6F1A93A0AQ37190414-2A9B25FC-3A0F-40F3-B858-BE60BF8F4066Q37706407-0998CA2A-DE54-4E14-9BF3-99462FF92360Q38765793-8A5C024B-B467-44CC-80FC-D6567359E673Q40096622-61408805-C8B5-4223-BA2E-A11E75AB1279Q40248157-58D4F1FC-E8F1-480B-92BE-B04E9A3E0F69Q45771313-A6A4F317-BDA7-43A4-89DE-06B0187D273BQ47302138-A727B269-851F-415C-9574-C4177B2FE341Q51615433-47A343E5-4E10-4D9E-A664-EE336D4519F0Q54975879-C1D12774-97FB-42F4-9BF4-35EEC2DC8025Q55438036-F6669B43-A50B-4222-9FA1-3BEC11416362
P2860
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
@ast
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
@en
type
label
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
@ast
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
@en
prefLabel
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
@ast
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
@en
P2093
P2860
P356
P1476
BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib
@en
P2093
A M Sieuwerts
E F Petricoin
J A Foekens
J D Wulfkuhle
L C J Dorssers
M F E Godinho
S Sleijfer
T van Agthoven
P2860
P2888
P304
P356
10.1038/BJC.2012.351
P407
P577
2012-08-14T00:00:00Z